Physician
Privia Medical Group Arizona, LLC
Privia Medical Group Arizona, LLC was paid $45.65M by Medicaid between Jan 2018 and Dec 2024, across 221 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoPRIVIA MEDICAL GROUP ARIZONA, LLC
PHOENIX, AZ 85032
PHOENIX, AZ 85032
33aNPI1760441141assigned 03/22/2006
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$45.65M
24GClaims828,576
24DCodes billed221
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Arizona
Rank by total paid#1 of 28
Median peer was paid$308K
This provider vs. median148×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 121,125 | $6.54M | |
| 2019 | 110,843 | $6.30M | |
| 2020 | 108,503 | $6.39M | |
| 2021 | 161,998 | $6.58M | |
| 2022 | 154,396 | $6.73M | |
| 2023 | 88,374 | $6.14M | |
| 2024incomplete | 83,337 | $6.97M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 260,754 | 239,723 | $15.70M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 106,402 | 99,462 | $4.65M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 6.6% | 26,004 | 25,430 | $3.01M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.7% | 29,565 | 28,718 | $2.62M |
| 95715 | 4.8% | 946 | 386 | $2.20M | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4.1% | 8,871 | 8,151 | $1.87M |
| 95819 | 2.9% | 4,342 | 4,257 | $1.31M | |
| 95911 | 2.8% | 7,367 | 5,987 | $1.29M | |
| 95886 | 2.5% | 7,658 | 6,372 | $1.16M | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.9% | 7,996 | 7,067 | $848K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 12,589 | 12,123 | $751K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.6% | 3,727 | 3,600 | $749K |
209 more codes
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.6% | 5,188 | $709K |
| J2785 | Injection, regadenoson, 0.1 mg | 1.3% | 5,220 | $578K |
| 93015 | 1.2% | 12,523 | $539K | |
| 93229 | 1.0% | 550 | $460K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,985 | $432K |
| 93970 | <1% | 3,369 | $381K | |
| 95816 | <1% | 1,246 | $378K | |
| 93880 | <1% | 3,247 | $349K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 1,511 | $295K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 3,493 | $293K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 897 | $274K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,041 | $273K |
| 93925 | <1% | 1,944 | $251K | |
| 93000 | <1% | 22,247 | $248K | |
| 20610 | <1% | 6,119 | $248K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 4,638 | $241K |
| 99243 | <1% | 2,607 | $236K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 700 | $219K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 4,838 | $206K |
| 99205 | Prolong outpt/office vis | <1% | 1,712 | $185K |
| 96132 | <1% | 1,948 | $177K | |
| 64483 | <1% | 669 | $135K | |
| 99223 | Prolong inpt eval add15 m | <1% | 1,122 | $123K |
| 99442 | <1% | 2,419 | $116K | |
| 93922 | <1% | 2,165 | $104K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 904 | $87K |
| 64635 | <1% | 393 | $82K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 1,535 | $80K |
| 95700 | <1% | 388 | $80K | |
| 99443 | <1% | 1,271 | $78K | |
| 95724 | <1% | 271 | $73K | |
| 64636 | <1% | 387 | $65K | |
| 43249 | <1% | 122 | $63K | |
| 95117 | <1% | 7,686 | $61K | |
| 31231 | <1% | 410 | $58K | |
| 93227 | <1% | 3,176 | $56K | |
| 93225 | <1% | 3,169 | $55K | |
| 95951 | <1% | 82 | $55K | |
| 96138 | <1% | 1,950 | $49K | |
| 99152 | <1% | 1,971 | $48K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,933 | $43K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 416 | $40K |
| 30140 | <1% | 156 | $40K | |
| 95712 | <1% | 13 | $35K | |
| 64721 | <1% | 108 | $34K | |
| 73630 | <1% | 1,331 | $33K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 720 | $31K |
| 36475 | <1% | 42 | $29K | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 119 | $27K |
| 95251 | <1% | 1,110 | $25K | |
| 73130 | <1% | 933 | $24K | |
| 90686 | <1% | 1,613 | $24K | |
| 92557 | <1% | 877 | $24K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,761 | $23K |
| 93458 | <1% | 118 | $21K | |
| 93295 | <1% | 920 | $21K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 224 | $21K |
| 20611 | <1% | 284 | $20K | |
| 93298 | <1% | 1,199 | $20K | |
| 73562 | <1% | 827 | $20K | |
| 93296 | <1% | 1,613 | $19K | |
| 95885 | <1% | 202 | $19K | |
| 93923 | <1% | 228 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,245 | $17K |
| 93978 | <1% | 175 | $16K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 643 | $16K |
| 99490 | Ccm add 20min | <1% | 1,809 | $15K |
| 93971 | <1% | 215 | $14K | |
| 92567 | <1% | 1,246 | $13K | |
| 93228 | <1% | 603 | $12K | |
| 99253 | <1% | 136 | $12K | |
| 90682 | <1% | 272 | $12K | |
| S0285 | Colonoscopy consultation performed prior to a screening colonoscopy procedure | <1% | 89 | $12K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 184 | $12K |
| 99254 | <1% | 108 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,041 | $11K |
| 93241 | <1% | 75 | $11K | |
| 73030 | <1% | 526 | $11K | |
| 93294 | <1% | 806 | $11K | |
| 31579 | <1% | 100 | $11K | |
| 95024 | <1% | 246 | $10K | |
| 95913 | <1% | 41 | $9K | |
| 95910 | <1% | 70 | $9K | |
| 73110 | <1% | 303 | $7K | |
| 93297 | <1% | 543 | $7K | |
| 31575 | <1% | 76 | $7K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 26 | $7K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 201 | $7K |
| 64493 | <1% | 45 | $7K | |
| 11721 | <1% | 332 | $6K | |
| 93244 | <1% | 305 | $6K | |
| 36482 | <1% | 12 | $6K | |
| 93280 | <1% | 208 | $6K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,182 | $6K |
| 93975 | <1% | 25 | $5K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 21 | $5K |
| 31237 | <1% | 16 | $4K | |
| 20552 | <1% | 130 | $4K | |
| 99441 | <1% | 157 | $4K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 652 | $4K |
| 99245 | <1% | 23 | $4K | |
| 99385 | <1% | 37 | $4K | |
| 20550 | <1% | 90 | $4K | |
| 73600 | <1% | 155 | $4K | |
| 97802 | <1% | 42 | $4K | |
| 81002 | <1% | 1,391 | $4K | |
| 64494 | <1% | 43 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 416 | $3K |
| 93242 | <1% | 302 | $3K | |
| 92579 | <1% | 97 | $3K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 2,107 | $3K |
| 93793 | <1% | 434 | $3K | |
| 99349 | <1% | 23 | $2K | |
| 93299 | <1% | 370 | $2K | |
| 95115 | <1% | 325 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 147 | $2K |
| 90662 | <1% | 206 | $2K | |
| 94060 | <1% | 49 | $2K | |
| 85610 | <1% | 654 | $2K | |
| 96401 | <1% | 39 | $2K | |
| 69210 | <1% | 45 | $2K | |
| 99000 | <1% | 360 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,082 | $1K |
| 95909 | <1% | 14 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 528 | $1K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 384 | $1K |
| 64495 | <1% | 18 | $1K | |
| 98967 | <1% | 62 | $1K | |
| 11750 | <1% | 14 | $1K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 28 | $1K |
| 99494 | <1% | 38 | $1K | |
| J3490 | Unclassified drugs | <1% | 47 | $1K |
| 82962 | <1% | 819 | $1K | |
| 81025 | <1% | 194 | $1K | |
| 93016 | <1% | 82 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 15 | $1K |
| 80305 | <1% | 333 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,000 | $1K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 39 | $1K |
| 93018 | <1% | 82 | $816.42 | |
| 81003 | <1% | 766 | $807.81 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 41 | $766.75 |
| 99242 | <1% | 16 | $717.49 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 160 | $655.50 |
| 20526 | <1% | 13 | $639.65 | |
| 51798 | <1% | 57 | $473.91 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 359 | $432.13 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,321 | $406.47 |
| 98968 | <1% | 12 | $405.85 | |
| 90673 | <1% | 12 | $392.67 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,211 | $367.12 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 13 | $354.66 |
| 90674 | <1% | 15 | $345.41 | |
| 98925 | <1% | 14 | $320.44 | |
| 11720 | <1% | 14 | $286.97 | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | <1% | 156 | $246.72 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 26 | $225.42 |
| 90688 | <1% | 13 | $207.82 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 19 | $183.02 |
| 92587 | <1% | 12 | $177.99 | |
| G0008 | Administration of influenza virus vaccine | <1% | 271 | $159.36 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 114 | $149.88 |
| 95012 | <1% | 15 | $129.30 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 37 | $112.62 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 526 | $95.75 |
| 86580 | <1% | 18 | $95.02 | |
| 1036F | <1% | 14,646 | $70.48 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 36 | $64.60 |
| 99457 | <1% | 28 | $56.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $29.10 |
| 82948 | <1% | 15 | $25.25 | |
| 3008F | <1% | 34,713 | $3.05 | |
| 3725F | <1% | 6,444 | $1.47 | |
| 3074F | <1% | 17,038 | $1.03 | |
| 1159F | <1% | 23,625 | $0.83 | |
| 1160F | <1% | 30,422 | $0.82 | |
| 3078F | <1% | 10,033 | $0.55 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $0.44 |
| 99499 | <1% | 91 | $0.18 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 5,996 | $0.12 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 5,797 | $0.11 |
| 1126F | <1% | 1,141 | $0.06 | |
| 3079F | <1% | 10,680 | $0.04 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | <1% | 201 | $0.02 |
| 1125F | <1% | 754 | $0.01 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 1,701 | $0.01 |
| 2010F | 0% | 3,522 | $0.00 | |
| 3044F | 0% | 761 | $0.00 | |
| 3075F | 0% | 2,303 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 474 | $0.00 |
| 99024 | 0% | 162 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,163 | $0.00 |
| 3017F | 0% | 160 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,772 | $0.00 |
| 3080F | 0% | 372 | $0.00 | |
| 1034F | 0% | 542 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 88 | $0.00 |
| 3014F | 0% | 92 | $0.00 | |
| 3072F | 0% | 184 | $0.00 | |
| 1111F | 0% | 108 | $0.00 | |
| 4010F | 0% | 14 | $0.00 | |
| 3077F | 0% | 1,021 | $0.00 | |
| 4013F | 0% | 382 | $0.00 | |
| 3016F | 0% | 22 | $0.00 | |
| 3288F | 0% | 269 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 342 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 80 | $0.00 |
| 3045F | 0% | 21 | $0.00 | |
| 2022F | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCHORNEY, MICHAEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Privia Medical Group Arizona, LLC | Payson, AZ | $792.55 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.